- Home
- AUPH vs MD Comparison
AUPH vs MD Comparison
Compare AUPH & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | MD |
|---|---|---|
| Founded | 1993 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.0B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUPH | MD |
|---|---|---|
| Price | $15.75 | $22.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $17.25 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.55 | ★ 1.91 |
| Revenue | $265,808,000.00 | ★ $1,922,442,000.00 |
| Revenue This Year | $21.22 | N/A |
| Revenue Next Year | $15.40 | $2.70 |
| P/E Ratio | $28.81 | ★ $11.79 |
| Revenue Growth | ★ 20.62 | N/A |
| 52 Week Low | $6.55 | $11.84 |
| 52 Week High | $16.48 | $24.99 |
Technical Indicators
Market Signals| Indicator | AUPH | MD |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 56.42 |
| Support Level | $15.15 | $21.10 |
| Resistance Level | $16.03 | $24.99 |
| Average True Range (ATR) | 0.50 | 0.78 |
| MACD | -0.12 | -0.30 |
| Stochastic Oscillator | 57.02 | 40.87 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.